Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy.
Nat Rev Immunol. 2023 Feb;23(2):90-105. doi: 10.1038/s41577-022-00732-1. Epub 2022 May 30.
Nat Rev Immunol. 2023.
PMID: 35637393
Review.
NK cells mediate clearance of CD8+ T cell-resistant tumors in response to STING agonists.
Nicolai CJ, Wolf N, Chang IC, Kirn G, Marcus A, Ndubaku CO, McWhirter SM, Raulet DH.
Nicolai CJ, et al.
Sci Immunol. 2020 Mar 20;5(45):eaaz2738. doi: 10.1126/sciimmunol.aaz2738.
Sci Immunol. 2020.
PMID: 32198222
Free PMC article.
Item in Clipboard
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors.
Wolf NK, Blaj C, Picton LK, Snyder G, Zhang L, Nicolai CJ, Ndubaku CO, McWhirter SM, Garcia KC, Raulet DH.
Wolf NK, et al.
Proc Natl Acad Sci U S A. 2022 May 31;119(22):e2200568119. doi: 10.1073/pnas.2200568119. Epub 2022 May 19.
Proc Natl Acad Sci U S A. 2022.
PMID: 35588144
Free PMC article.
Item in Clipboard
Killer cells add fire to fuel immunotherapy.
Nicolai CJ, Raulet DH.
Nicolai CJ, et al.
Science. 2020 May 29;368(6494):943-944. doi: 10.1126/science.abc2502.
Science. 2020.
PMID: 32467380
No abstract available.
Item in Clipboard
Tumor-induced disruption of the blood-brain barrier promotes host death.
Kim J, Chuang HC, Wolf NK, Nicolai CJ, Raulet DH, Saijo K, Bilder D.
Kim J, et al.
Dev Cell. 2021 Oct 11;56(19):2712-2721.e4. doi: 10.1016/j.devcel.2021.08.010. Epub 2021 Sep 7.
Dev Cell. 2021.
PMID: 34496290
Free PMC article.
Item in Clipboard
Cytosolic bacterial pathogens activate TLR pathways in tumors that synergistically enhance STING agonist cancer therapies.
Danielson M, Nicolai CJ, Vo TT, Wolf N, Burke TP.
Danielson M, et al.
bioRxiv [Preprint]. 2024 Feb 2:2024.01.30.578087. doi: 10.1101/2024.01.30.578087.
bioRxiv. 2024.
PMID: 38352567
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite